Strain Name:

NOD.129S2(Cg)-Stat6tm1Gru/JbsJ

Stock Number:

004672

Availability:

Repository-Cryopreserved

Use Restrictions Apply, see Terms of Use

Description

Strain Information

Former Names NOD.129S2-Stat6tm1Gru/JbsJ    (Changed: 15-DEC-04 )
Type Congenic; Mutant Strain; Targeted Mutation;
Additional information on Genetically Engineered Mutant Mice.
Specieslaboratory mouse
Background Strain NOD/ShiLtJ
Donor Strain 129S2 (D3 ES cell derived)
H2 Haplotypeg7
 
Donating Investigator Jeffrey Bluestone,   University of California, San Francisco

Appearance
pink-eyed albino
Related Genotype: A/A Tyrc/Tyrc

Description
NOD mice homozygous for the Stat6tm1Gru mutation exhibit an increased diabetes incidence compared to NOD controls and show a striking defect in the generation of Th2 cells. Lymphocytes are unable to respond to IL4 as measured in a variety of in vitro and in vivo assays. This strain can be used to look at the role of Il4 in diabetes development.

Control Information

  Control
   001976 NOD/ShiLtJ
 
  Considerations for Choosing Controls

Related Strains

Strains carrying   Stat6tm1Gru allele
005977   B6.129S2(C)-Stat6tm1Gru/J
003750   C.129S2-Stat4tm1Gru Stat6tm1Gru/J
002828   C.129S2-Stat6tm1Gru/J
View Strains carrying   Stat6tm1Gru     (3 strains)

Additional Web Information

Congenic Nomenclature

Phenotype

Phenotype Information

View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Cancer Research
Growth Factors/Receptors/Cytokines

Diabetes and Obesity Research
Type 1 Diabetes (IDDM)
Type 1 Diabetes (IDDM) Analysis Strains (NOD Congenics with Mutations Affecting Cytokine Production by Autoreactive T Cells)

Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Growth Factors/Receptors/Cytokines

Stat6tm1Gru related

Immunology and Inflammation Research
Immunodeficiency
Intracellular Signaling Molecules

Genes & Alleles

Gene & Allele Information

Allele Symbol Stat6tm1Gru
Allele Name targeted mutation 1, Michael J Grusby
Allele Type Targeted (knock-out)
Common Name(s) Stat6-;
Mutation Made By Michael Grusby,   Harvard Medical School
Strain of Origin129S2/SvPas
ES Cell Line NameD3
ES Cell Line Strain129S2/SvPas
Gene Symbol and Name Stat6, signal transducer and activator of transcription 6
Chromosome 10
Gene Common Name(s) D12S1644; IL-4-STAT; STAT6B; STAT6C;
Molecular Note The region encoding the SH2 domain, which is essential for dimerization, was replaced by the insertion of a neomycin selection cassette. Immunoblot analysis of lysates from the spleens and thymi of homozygous mutant mice showed an absence of encoded protein. [MGI Ref ID J:31932]

Genotyping

Genotyping Information

Genotyping Protocols

Stat6tm1Gru, STD PCR, vers. 2

Helpful Links

Optimizing PCR Protocols

References

References

Selected Reference(s)

Kaplan MH; Schindler U; Smiley ST; Grusby MJ. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4(3):313-9. [PubMed: 8624821]  [MGI Ref ID J:31932]

Additional References

Stat6tm1Gru related

Agarwal S; Rao A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9(6):765-75. [PubMed: 9881967]  [MGI Ref ID J:51833]

Amsen D; Antov A; Jankovic D; Sher A; Radtke F; Souabni A; Busslinger M; McCright B; Gridley T; Flavell RA. 2007. Direct regulation of gata3 expression determines the T helper differentiation potential of notch. Immunity 27(1):89-99. [PubMed: 17658279]  [MGI Ref ID J:123631]

Armstrong BD; Abad C; Chhith S; Cheung-Lau G; Hajji OE; Coute AC; Ngo DH; Waschek JA. 2006. Impairment of axotomy-induced pituitary adenylyl cyclase-activating peptide gene expression in T helper 2 lymphocyte-deficient mice. Neuroreport 17(3):309-12. [PubMed: 16462603]  [MGI Ref ID J:106085]

Bian K; Zhong M; Harari Y; Lai M; Weisbrodt N; Murad F. 2005. Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis. Proc Natl Acad Sci U S A 102(11):3936-41. [PubMed: 15741272]  [MGI Ref ID J:97167]

Blease K; Schuh JM; Jakubzick C; Lukacs NW; Kunkel SL; Joshi BH; Puri RK; Kaplan MH; Hogaboam CM. 2002. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 160(2):481-90. [PubMed: 11839568]  [MGI Ref ID J:74497]

Bour-Jordan H; Grogan JL; Tang Q; Auger JA; Locksley RM; Bluestone JA. 2003. CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nat Immunol 4(2):182-8. [PubMed: 12524538]  [MGI Ref ID J:126980]

Broxmeyer HE; Bruns HA; Zhang S; Cooper S; Hangoc G; McKenzie AN; Dent AL; Schindler U; Naeger LK; Hoey T; Kaplan MH. 2002. Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin m. Immunity 16(6):815-25. [PubMed: 12121663]  [MGI Ref ID J:77523]

Bunting KD; Yu WM; Bradley HL; Haviernikova E; Kelly-Welch AE; Keegan AD; Qu CK. 2004. Increased numbers of committed myeloid progenitors but not primitive hematopoietic stem/progenitors in mice lacking STAT6 expression. J Leukoc Biol 76(2):484-90. [PubMed: 15123777]  [MGI Ref ID J:91477]

Burgis S; Gessner A. 2007. Unexpected phenotype of STAT6 heterozygous mice implies distinct STAT6 dosage requirements for different IL-4 functions. Int Arch Allergy Immunol 143(4):263-8. [PubMed: 17347574]  [MGI Ref ID J:140305]

Castilow EM; Legge KL; Varga SM. 2008. Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease. J Immunol 181(10):6692-6. [PubMed: 18981084]  [MGI Ref ID J:140954]

Chang HC; Zhang S; Kaplan MH. 2002. Neonatal tolerance in the absence of Stat4- and Stat6- dependent Th cell differentiation. J Immunol 169(8):4124-8. [PubMed: 12370340]  [MGI Ref ID J:120160]

Chang S; Aune TM. 2007. Dynamic changes in histone-methylation 'marks' across the locus encoding interferon-gamma during the differentiation of T helper type 2 cells. Nat Immunol 8(7):723-31. [PubMed: 17546034]  [MGI Ref ID J:123355]

Chen CC; Louie S; McCormick B; Walker WA; Shi HN. 2005. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect Immun 73(9):5468-81. [PubMed: 16113263]  [MGI Ref ID J:100416]

Chen Z; Lund R; Aittokallio T; Kosonen M; Nevalainen O; Lahesmaa R. 2003. Identification of novel IL-4/Stat6-regulated genes in T lymphocytes. J Immunol 171(7):3627-35. [PubMed: 14500660]  [MGI Ref ID J:107367]

Chesler DA; Reiss CS. 2002. IL-12, while beneficial, is not essential for the host response to VSV encephalitis. J Neuroimmunol 131(1-2):92-7. [PubMed: 12458040]  [MGI Ref ID J:102956]

Chitnis T; Najafian N; Benou C; Salama AD; Grusby MJ; Sayegh MH; Khoury SJ. 2001. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 108(5):739-47. [PubMed: 11544280]  [MGI Ref ID J:71460]

Chitnis T; Salama AD; Grusby MJ; Sayegh MH; Khoury SJ. 2004. Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. J Immunol 172(7):4260-5. [PubMed: 15034039]  [MGI Ref ID J:88725]

Chung DR; Kasper DL; Panzo RJ; Chtinis T; Grusby MJ; Sayegh MH; Tzianabos AO. 2003. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 170(4):1958-63. [PubMed: 12574364]  [MGI Ref ID J:81809]

Devoss JJ; Shum AK; Johannes KP; Lu W; Krawisz AK; Wang P; Yang T; Leclair NP; Austin C; Strauss EC; Anderson MS. 2008. Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1. J Immunol 181(6):4072-9. [PubMed: 18768863]  [MGI Ref ID J:139094]

Fang TC; Yashiro-Ohtani Y; Del Bianco C; Knoblock DM; Blacklow SC; Pear WS. 2007. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27(1):100-10. [PubMed: 17658278]  [MGI Ref ID J:123632]

Finkelman FD; Morris SC; Orekhova T; Mori M; Donaldson D; Reiner SL; Reilly NL; Schopf L; Urban JF Jr. 2000. Stat6 regulation of in vivo IL-4 responses. J Immunol 164(5):2303-10. [PubMed: 10679064]  [MGI Ref ID J:112038]

Finnegan A; Grusby MJ; Kaplan CD; O'Neill SK; Eibel H; Koreny T; Czipri M; Mikecz K; Zhang J. 2002. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 169(6):3345-52. [PubMed: 12218156]  [MGI Ref ID J:120443]

Fraidakis MJ; Kiyotani T; Pernold K; Bergstrom J; Olson L. 2007. Recovery from spinal cord injury in tumor necrosis factor-alpha, signal transducers and activators of transcription 4 and signal transducers and activators of transcription 6 null mice. Neuroreport 18(2):185-9. [PubMed: 17301687]  [MGI Ref ID J:120345]

Ghiasi H; Osorio Y; Nesburn AB; Wechsler SL. 2002. Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2. Virology 302(2):286-93. [PubMed: 12441072]  [MGI Ref ID J:107370]

Haczku A; Cao Y; Vass G; Kierstein S; Nath P; Atochina-Vasserman EN; Scanlon ST; Li L; Griswold DE; Chung KF; Poulain FR; Hawgood S; Beers MF; Crouch EC. 2006. IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol 176(6):3557-65. [PubMed: 16517724]  [MGI Ref ID J:129507]

Hadeiba H; Locksley RM. 2003. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J Immunol 170(11):5502-10. [PubMed: 12759427]  [MGI Ref ID J:109990]

Harrington LE; Hatton RD; Mangan PR; Turner H; Murphy TL; Murphy KM; Weaver CT. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11):1123-32. [PubMed: 16200070]  [MGI Ref ID J:112601]

Harris MB; Chang CC; Berton MT; Danial NN; Zhang J; Kuehner D; Ye BH; Kvatyuk M; Pandolfi PP; Cattoretti G; Dalla-Favera R; Rothman PB. 1999. Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol 19(10):7264-75. [PubMed: 10490661]  [MGI Ref ID J:57856]

Herold KC; Lu J; Rulifson I; Vezys V; Taub D; Grusby MJ; Bluestone JA. 1997. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J Immunol 159(9):4150-3. [PubMed: 9379007]  [MGI Ref ID J:110673]

Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG. 1999. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J Immunol 163(10):5374-82. [PubMed: 10553062]  [MGI Ref ID J:107047]

Hoshino A; Tsuji T; Matsuzaki J; Jinushi T; Ashino S; Teramura T; Chamoto K; Tanaka Y; Asakura Y; Sakurai T; Mita Y; Takaoka A; Nakaike S; Takeshima T; Ikeda H; Nishimura T. 2004. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int Immunol 16(10):1497-505. [PubMed: 15351784]  [MGI Ref ID J:93632]

Howell MD; Gallo RL; Boguniewicz M; Jones JF; Wong C; Streib JE; Leung DY. 2006. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24(3):341-8. [PubMed: 16546102]  [MGI Ref ID J:113325]

Huber SA; Sakkinen P; David C; Newell MK; Tracy RP. 2001. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103(21):2610-6. [PubMed: 11382732]  [MGI Ref ID J:133189]

Ingram JL; Antao-Menezes A; Mangum JB; Lyght O; Lee PJ; Elias JA; Bonner JC. 2006. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J Immunol 177(6):4141-8. [PubMed: 16951379]  [MGI Ref ID J:138041]

Iribarren P; Chen K; Hu J; Zhang X; Gong W; Wang JM. 2005. IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia. J Immunol 175(9):6100-6. [PubMed: 16237106]  [MGI Ref ID J:119383]

Ishikawa Y; Yoshimoto T; Nakanishi K. 2006. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness. Int Immunol 18(6):847-55. [PubMed: 16611648]  [MGI Ref ID J:109098]

Jacob CO; Zang S; Li L; Ciobanu V; Quismorio F; Mizutani A; Satoh M; Koss M. 2003. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 171(3):1564-71. [PubMed: 12874250]  [MGI Ref ID J:120665]

Jaruga B; Hong F; Sun R; Radaeva S; Gao B. 2003. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171(6):3233-44. [PubMed: 12960353]  [MGI Ref ID J:85386]

Jensen SM; Meijer SL; Kurt RA; Urba WJ; Hu HM; Fox BA. 2003. Regression of a mammary adenocarcinoma in STAT6-/- mice is dependent on the presence of STAT6-reactive T cells. J Immunol 170(4):2014-21. [PubMed: 12574371]  [MGI Ref ID J:107369]

Jessup HK; Brewer AW; Omori M; Rickel EA; Budelsky AL; Yoon BR; Ziegler SF; Comeau MR. 2008. Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response. J Immunol 181(6):4311-9. [PubMed: 18768889]  [MGI Ref ID J:139079]

Junttila IS; Mizukami K; Dickensheets H; Meier-Schellersheim M; Yamane H; Donnelly RP; Paul WE. 2008. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J Exp Med 205(11):2595-608. [PubMed: 18852293]  [MGI Ref ID J:141103]

Kacha AK; Fallarino F; Markiewicz MA; Gajewski TF. 2000. Spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice J Immunol 165(11):6024-8. [PubMed: 11086033]  [MGI Ref ID J:65893]

Kaplan MH; Wurster AL; Grusby MJ. 1998. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J Exp Med 188(6):1191-6. [PubMed: 9743537]  [MGI Ref ID J:50032]

Kaplan MH; Wurster AL; Smiley ST; Grusby MJ. 1999. Stat6-dependent and -independent pathways for IL-4 production. J Immunol 163(12):6536-40. [PubMed: 10586046]  [MGI Ref ID J:112135]

Kato A; Yoshidome H; Edwards MJ; Lentsch AB. 2000. Regulation of liver inflammatory injury by signal transducer and activator of transcription-6. Am J Pathol 157(1):297-302. [PubMed: 10880399]  [MGI Ref ID J:63136]

Ketavarapu JM; Rodriguez AR; Yu JJ; Cong Y; Murthy AK; Forsthuber TG; Guentzel MN; Klose KE; Berton MT; Arulanandam BP. 2008. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc Natl Acad Sci U S A 105(27):9313-8. [PubMed: 18591675]  [MGI Ref ID J:138191]

Khaled WT; Read EK; Nicholson SE; Baxter FO; Brennan AJ; Came PJ; Sprigg N; McKenzie AN; Watson CJ. 2007. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development 134(15):2739-50. [PubMed: 17611223]  [MGI Ref ID J:124116]

King SB; Knorn AM; Ohnmacht C; Voehringer D. 2008. Accumulation of effector CD4 T cells during type 2 immune responses is negatively regulated by Stat6. J Immunol 180(2):754-63. [PubMed: 18178813]  [MGI Ref ID J:130967]

Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H Jr; Grusby MJ; Khoury SJ; Sayegh MH. 2000. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 106(1):63-72. [PubMed: 10880049]  [MGI Ref ID J:63156]

Kriebel P; Patel BK; Nelson SA; Grusby MJ; LaRochelle WJ. 1999. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene 18(51):7294-302. [PubMed: 10602484]  [MGI Ref ID J:59015]

Kuperman D; Schofield B; Wills-Karp M; Grusby MJ. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187(6):939-48. [PubMed: 9500796]  [MGI Ref ID J:66222]

Kuperman DA; Huang X; Koth LL; Chang GH; Dolganov GM; Zhu Z; Elias JA; Sheppard D; Erle DJ. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8(8):885-9. [PubMed: 12091879]  [MGI Ref ID J:132385]

Kusmartsev S; Gabrilovich DI. 2005. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol 174(8):4880-91. [PubMed: 15814715]  [MGI Ref ID J:109996]

Land KJ; Gudapati P; Kaplan MH; Seetharamaiah GS. 2006. Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism. Endocrinology 147(1):111-9. [PubMed: 16195404]  [MGI Ref ID J:129448]

Le Saux CJ; Teeters K; Miyasato SK; Hoffmann PR; Bollt O; Douet V; Shohet RV; Broide DH; Tam EK. 2008. Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling. J Biol Chem 283(9):5760-8. [PubMed: 18056268]  [MGI Ref ID J:132297]

Lee CG; Homer RJ; Cohn L; Link H; Jung S; Craft JE; Graham BS; Johnson TR; Elias JA. 2002. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 277(38):35466-74. [PubMed: 12107190]  [MGI Ref ID J:79116]

Lee PJ; Zhang X; Shan P; Ma B; Lee CG; Homer RJ; Zhu Z; Rincon M; Mossman BT; Elias JA. 2006. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 116(1):163-73. [PubMed: 16374521]  [MGI Ref ID J:105338]

Levings MK; Schrader JW. 1999. IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol 162(9):5224-9. [PubMed: 10227996]  [MGI Ref ID J:112259]

Li W; Sofi MH; Yeh N; Sehra S; McCarthy BP; Patel DR; Brutkiewicz RR; Kaplan MH; Chang CH. 2007. Thymic selection pathway regulates the effector function of CD4 T cells. J Exp Med 204(9):2145-57. [PubMed: 17724129]  [MGI Ref ID J:126084]

Lin W; Truong N; Grossman WJ; Haribhai D; Williams CB; Wang J; Martin MG; Chatila TA. 2005. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol 116(5):1106-15. [PubMed: 16275384]  [MGI Ref ID J:117165]

Linehan LA; Warren WD; Thompson PA; Grusby MJ; Berton MT. 1998. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol 161(1):302-10. [PubMed: 9647237]  [MGI Ref ID J:110888]

Liu Q; Arseculeratne C; Liu Z; Whitmire J; Grusby MJ; Finkelman FD; Darling TN; Cheever AW; Swearengen J; Urban JF; Gause WC. 2004. Simultaneous deficiency in CD28 and STAT6 results in chronic ectoparasite-induced inflammatory skin disease. Infect Immun 72(7):3706-15. [PubMed: 15213110]  [MGI Ref ID J:90987]

Madden KB; Whitman L; Sullivan C; Gause WC; Urban JF Jr; Katona IM; Finkelman FD; Shea-Donohue T. 2002. Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol 169(8):4417-22. [PubMed: 12370375]  [MGI Ref ID J:120045]

Madden KB; Yeung KA; Zhao A; Gause WC; Finkelman FD; Katona IM; Urban JF Jr; Shea-Donohue T. 2004. Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol 172(9):5616-21. [PubMed: 15100305]  [MGI Ref ID J:89646]

Maerten P; Shen C; Bullens DM; Van Assche G; Van Gool S; Geboes K; Rutgeerts P; Ceuppens JL. 2005. Effects of interleukin 4 on CD25+CD4+ regulatory T cell function. J Autoimmun 25(2):112-20. [PubMed: 16051465]  [MGI Ref ID J:102760]

Mathew A; MacLean JA; DeHaan E; Tager AM; Green FH; Luster AD. 2001. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med 193(9):1087-96. [PubMed: 11342593]  [MGI Ref ID J:120521]

Matsukawa A; Kaplan MH; Hogaboam CM; Lukacs NW; Kunkel SL. 2001. Pivotal role of signal transducer and activator of transcription (stat)4 and stat6 in the innate immune response during sepsis. J Exp Med 193(6):679-88. [PubMed: 11257135]  [MGI Ref ID J:68143]

Mikhak Z; Fleming CM; Medoff BD; Thomas SY; Tager AM; Campanella GS; Luster AD. 2006. STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells. J Immunol 176(8):4959-67. [PubMed: 16585592]  [MGI Ref ID J:131153]

Mishra A; Wang M; Schlotman J; Nikolaidis NM; DeBrosse CW; Karow ML; Rothenberg ME. 2007. Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am J Physiol Lung Cell Mol Physiol 293(2):L305-13. [PubMed: 17545488]  [MGI Ref ID J:125839]

Moreno JL; Mikhailenko I; Tondravi MM; Keegan AD. 2007. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J Leukoc Biol 82(6):1542-53. [PubMed: 17855502]  [MGI Ref ID J:129938]

Morimoto M; Morimoto M; Zhao A; Madden KB; Dawson H; Finkelman FD; Mentink-Kane M; Urban JF Jr; Wynn TA; Shea-Donohue T. 2006. Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J Immunol 176(1):491-5. [PubMed: 16365442]  [MGI Ref ID J:126259]

Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H. 2005. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development. J Leukoc Biol 78(3):753-61. [PubMed: 16126843]  [MGI Ref ID J:100501]

Morris SC; Orekhova T; Meadows MJ; Heidorn SM; Yang J; Finkelman FD. 2006. IL-4 induces in vivo production of IFN-gamma by NK and NKT cells. J Immunol 176(9):5299-305. [PubMed: 16621996]  [MGI Ref ID J:131660]

Morse HC 3rd; McCarty T; Giese NA; Taddesse-Heath L; Grusby MJ. 1999. STAT6-deficient mice exhibit normal induction of murine AIDS and expression of immunoglobulin E following infection with LP-BM5 murine leukemia viruses. J Virol 73(8):7093-5. [PubMed: 10400816]  [MGI Ref ID J:56313]

Munitz A; McBride ML; Bernstein JS; Rothenberg ME. 2008. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 111(12):5694-703. [PubMed: 18316626]  [MGI Ref ID J:136634]

Nandakumar KS; Holmdahl R. 2006. Arthritis induced with cartilage-specific antibodiesis IL-4-dependent. Eur J Immunol 36(6):1608-18. [PubMed: 16688680]  [MGI Ref ID J:115066]

Nikolic B; Lee S; Bronson RT; Grusby MJ; Sykes M. 2000. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 105(9):1289-98. [PubMed: 10792004]  [MGI Ref ID J:62114]

Nurieva RI; Chung Y; Hwang D; Yang XO; Kang HS; Ma L; Wang YH; Watowich SS; Jetten AM; Tian Q; Dong C. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29(1):138-49. [PubMed: 18599325]  [MGI Ref ID J:137869]

Ong CJ; Ip S; Teh SJ; Wong C; Jirik FR; Grusby MJ; Teh HS. 1999. A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice. Cell Immunol 196(1):60-8. [PubMed: 10486156]  [MGI Ref ID J:57957]

Ostrand-Rosenberg S; Clements VK; Terabe M; Park JM; Berzofsky JA; Dissanayake SK. 2002. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent. J Immunol 169(10):5796-804. [PubMed: 12421960]  [MGI Ref ID J:80028]

Ostrand-Rosenberg S; Grusby MJ; Clements VK. 2000. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma J Immunol 165(11):6015-9. [PubMed: 11086031]  [MGI Ref ID J:65894]

Ostrand-Rosenberg S; Sinha P; Clements V; Dissanayake SI; Miller S; Davis C; Danna E. 2004. Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease. Cancer Immunol Immunother 53(2):86-91. [PubMed: 14593499]  [MGI Ref ID J:86509]

Ouyang W; Ranganath SH; Weindel K; Bhattacharya D; Murphy TL; Sha WC; Murphy KM. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9(5):745-55. [PubMed: 9846495]  [MGI Ref ID J:51355]

Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH. 2006. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. J Biol Chem 281(5):2414-29. [PubMed: 16251181]  [MGI Ref ID J:107499]

Park JH; Adoro S; Lucas PJ; Sarafova SD; Alag AS; Doan LL; Erman B; Liu X; Ellmeier W; Bosselut R; Feigenbaum L; Singer A. 2007. 'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol 8(10):1049-59. [PubMed: 17873878]  [MGI Ref ID J:125259]

Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH. 2005. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus. Cell Immunol 233(1):30-40. [PubMed: 15876426]  [MGI Ref ID J:99357]

Reece JJ; Siracusa MC; Southard TL; Brayton CF; Urban JF Jr; Scott AL. 2008. Hookworm-induced persistent changes to the immunological environment of the lung. Infect Immun 76(8):3511-24. [PubMed: 18505812]  [MGI Ref ID J:139393]

Reese TA; Liang HE; Tager AM; Luster AD; Van Rooijen N; Voehringer D; Locksley RM. 2007. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447(7140):92-6. [PubMed: 17450126]  [MGI Ref ID J:122735]

Rodriguez M; Zoecklein L; Gamez JD; Pavelko KD; Papke LM; Nakane S; Howe C; Radhakrishnan S; Hansen MJ; David CS; Warrington AE; Pease LR. 2006. STAT4- and STAT6-signaling molecules in a murine model of multiple sclerosis. FASEB J 20(2):343-5. [PubMed: 16352646]  [MGI Ref ID J:105734]

Rodriguez-Galan MC; Bream JH; Farr A; Young HA. 2005. Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression. J Immunol 174(5):2796-804. [PubMed: 15728489]  [MGI Ref ID J:97710]

Rodriguez-Sosa M; David JR; Bojalil R; Satoskar AR; Terrazas LI. 2002. Cutting edge: susceptibility to the larval stage of the Helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. J Immunol 168(7):3135-9. [PubMed: 11907063]  [MGI Ref ID J:75481]

Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR. 2005. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Int Immunol 17(10):1347-57. [PubMed: 16141242]  [MGI Ref ID J:101701]

Rose S; Guevara P; Farach S; Adkins B. 2006. The key regulators of adult T helper cell responses, STAT6 and T-bet, are established in early life in mice. Eur J Immunol 36(5):1241-53. [PubMed: 16568497]  [MGI Ref ID J:114781]

Sanchez-Guajardo V; Borghans JA; Marquez ME; Garcia S; Freitas AA. 2005. Different competitive capacities of Stat4- and Stat6-deficient CD4+ T cells during lymphophenia-driven proliferation. J Immunol 174(3):1178-87. [PubMed: 15661871]  [MGI Ref ID J:96425]

Sasaki K; Zhao X; Pardee AD; Ueda R; Fujita M; Sehra S; Kaplan MH; Kane LP; Okada H; Storkus WJ. 2008. Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J Immunol 181(1):104-8. [PubMed: 18566374]  [MGI Ref ID J:137362]

Sehra S; Patel D; Kusam S; Wang ZY; Chang CH; Dent AL. 2005. A role for caspases in controlling IL-4 expression in T cells. J Immunol 174(6):3440-6. [PubMed: 15749878]  [MGI Ref ID J:128888]

Shen R; Kaplan MH. 2002. The homeostasis but not the differentiation of T cells is regulated by p27(Kip1). J Immunol 169(2):714-21. [PubMed: 12097373]  [MGI Ref ID J:123837]

Shen XD; Ke B; Zhai Y; Gao F; Anselmo D; Lassman CR; Busuttil RW; Kupiec-Weglinski JW. 2003. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 37(2):296-303. [PubMed: 12540779]  [MGI Ref ID J:105818]

Shi HN; Grusby MJ; Nagler-Anderson C. 1999. Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J Immunol 162(9):5143-8. [PubMed: 10227985]  [MGI Ref ID J:112262]

Shirey KA; Cole LE; Keegan AD; Vogel SN. 2008. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol 181(6):4159-67. [PubMed: 18768873]  [MGI Ref ID J:139088]

Sho M; Yamada A; Najafian N; Salama AD; Harada H; Sandner SE; Sanchez-Fueyo A; Zheng XX; Strom TB; Sayegh MH. 2002. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 169(7):3744-51. [PubMed: 12244168]  [MGI Ref ID J:120408]

Simovic MO; Ballard BR; Gray KD; Stain SC. 2007. The STAT4 and STAT6 pathways in pancreatitis-associated lung injury. J Surg Res 137(1):10-5. [PubMed: 17109890]  [MGI Ref ID J:128064]

Singh RR; Saxena V; Zang S; Li L; Finkelman FD; Witte DP; Jacob CO. 2003. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 170(9):4818-25. [PubMed: 12707364]  [MGI Ref ID J:123824]

Sinha P; Clements VK; Ostrand-Rosenberg S. 2005. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res 65(24):11743-51. [PubMed: 16357187]  [MGI Ref ID J:104344]

Solymar DC; Agarwal S; Bassing CH; Alt FW; Rao A. 2002. A 3' enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity 17(1):41-50. [PubMed: 12150890]  [MGI Ref ID J:78089]

Spencer L; Shultz L; Rajan TV. 2001. Interleukin-4 receptor-stat6 signaling in murine infections with a tissue-dwelling nematode parasite. Infect Immun 69(12):7743-52. [PubMed: 11705956]  [MGI Ref ID J:73137]

Strait RT; Morris SC; Smiley K; Urban JF Jr; Finkelman FD. 2003. IL-4 exacerbates anaphylaxis. J Immunol 170(7):3835-42. [PubMed: 12646651]  [MGI Ref ID J:125442]

Tarleton RL; Grusby MJ; Zhang L. 2000. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J Immunol 165(3):1520-5. [PubMed: 10903759]  [MGI Ref ID J:120438]

Tawara I; Maeda Y; Sun Y; Lowler KP; Liu C; Toubai T; McKenzie AN; Reddy P. 2008. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol 36(8):988-96. [PubMed: 18410989]  [MGI Ref ID J:139377]

Tekkanat KK; Maassab HF; Cho DS; Lai JJ; John A; Berlin A; Kaplan MH; Lukacs NW. 2001. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol 166(5):3542-8. [PubMed: 11207314]  [MGI Ref ID J:126450]

Temann UA; Laouar Y; Eynon EE; Homer R; Flavell RA. 2007. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 19(1):1-10. [PubMed: 17101709]  [MGI Ref ID J:118163]

Terabe M; Khanna C; Bose S; Melchionda F; Mendoza A; Mackall CL; Helman LJ; Berzofsky JA. 2006. CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res 66(7):3869-75. [PubMed: 16585215]  [MGI Ref ID J:108313]

Turnbull IR; Gilfillan S; Cella M; Aoshi T; Miller M; Piccio L; Hernandez M; Colonna M. 2006. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 177(6):3520-4. [PubMed: 16951310]  [MGI Ref ID J:138057]

Ueno A; Cho S; Cheng L; Wang J; Hou S; Nakano H; Santamaria P; Yang Y. 2007. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes 56(6):1686-93. [PubMed: 17360980]  [MGI Ref ID J:126514]

Ueno T; Habicht A; Clarkson MR; Albin MJ; Yamaura K; Boenisch O; Popoola J; Wang Y; Yagita H; Akiba H; Ansari MJ; Yang J; Turka LA; Rothstein DM; Padera RF; Najafian N; Sayegh MH. 2008. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest 118(2):742-51. [PubMed: 18172549]  [MGI Ref ID J:131045]

Villarino AV; Tato CM; Stumhofer JS; Yao Z; Cui YK; Hennighausen L; O'Shea JJ; Hunter CA. 2007. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med 204(1):65-71. [PubMed: 17227909]  [MGI Ref ID J:125293]

Voehringer D; Reese TA; Huang X; Shinkai K; Locksley RM. 2006. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med 203(6):1435-46. [PubMed: 16702603]  [MGI Ref ID J:124383]

Voehringer D; Stanley SA; Cox JS; Completo GC; Lowary TL; Locksley RM. 2007. Nippostrongylus brasiliensis: identification of intelectin-1 and -2 as Stat6-dependent genes expressed in lung and intestine during infection. Exp Parasitol 116(4):458-66. [PubMed: 17420014]  [MGI Ref ID J:128858]

Wang J; Cho S; Ueno A; Cheng L; Xu BY; Desrosiers MD; Shi Y; Yang Y. 2008. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J Immunol 181(4):2438-45. [PubMed: 18684934]  [MGI Ref ID J:140188]

Wang W; Ostlie NS; Conti-Fine BM; Milani M. 2004. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells. J Immunol 172(1):97-103. [PubMed: 14688314]  [MGI Ref ID J:87570]

Wang ZY; Kusam S; Munugalavadla V; Kapur R; Brutkiewicz RR; Dent AL. 2006. Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFAT2. J Immunol 176(2):880-8. [PubMed: 16393972]  [MGI Ref ID J:126448]

Xu Z; Duan B; Croker BP; Morel L. 2006. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin Immunol 120(2):189-98. [PubMed: 16713741]  [MGI Ref ID J:113234]

Yamada A; Sheikh F; Niimi T; DeMayo FJ; Keegan AD; Donnelly RP; Kimura S. 2005. Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13. J Immunol 175(9):5708-15. [PubMed: 16237061]  [MGI Ref ID J:119343]

Yao Y; Li W; Kaplan MH; Chang CH. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 201(12):1899-903. [PubMed: 15967820]  [MGI Ref ID J:99206]

Yokota N; Burne-Taney M; Racusen L; Rabb H. 2003. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 285(2):F319-25. [PubMed: 12709397]  [MGI Ref ID J:84825]

Yu Q; Chang HC; Ahyi AN; Kaplan MH. 2008. Transcription factor-dependent chromatin remodeling of Il18r1 during Th1 and Th2 differentiation. J Immunol 181(5):3346-52. [PubMed: 18714006]  [MGI Ref ID J:138949]

Zhang S; Lawless VA; Kaplan MH. 2000. Cytokine-stimulated T lymphocyte proliferation is regulated by p27Kip1. J Immunol 165(11):6270-7. [PubMed: 11086062]  [MGI Ref ID J:112128]

Zhang Y; Kirken RA; Furian L; Janczewska S; Qu X; Hancock WW; Wang M; Tejpal N; Kerman R; Kahan BD; Stepkowski SM. 2006. Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. J Immunol 176(1):128-37. [PubMed: 16365403]  [MGI Ref ID J:126249]

Zhao A; Morimoto M; Dawson H; Elfrey JE; Madden KB; Gause WC; Min B; Finkelman FD; Urban JF Jr; Shea-Donohue T. 2005. Immune regulation of protease-activated receptor-1 expression in murine small intestine during Nippostrongylus brasiliensis infection. J Immunol 175(4):2563-9. [PubMed: 16081830]  [MGI Ref ID J:107492]

Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML. 2000. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol 165(10):5580-7. [PubMed: 11067913]  [MGI Ref ID J:119580]

Zhu J; Guo L; Min B; Watson CJ; Hu-Li J; Young HA; Tsichlis PN; Paul WE. 2002. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 16(5):733-44. [PubMed: 12049724]  [MGI Ref ID J:113530]

Zimmermann N; Mishra A; King NE; Fulkerson PC; Doepker MP; Nikolaidis NM; Kindinger LE; Moulton EA; Aronow BJ; Rothenberg ME. 2004. Transcript signatures in experimental asthma: identification of STAT6-dependent and -independent pathways. J Immunol 172(3):1815-24. [PubMed: 14734765]  [MGI Ref ID J:107368]

Health & husbandry

Health & Colony Maintenance Information

Colony Maintenance

Breeding & HusbandryA footpad injection of Complete Freund s Adjuvant (CFA) administered once at weaning will delay diabetes onset, thus extending the lifespan of breeders. Use of Complete Freund s Adjuvant in NOD mice can be found in Current Protocols in Immunology page 15.9.19, Reproduction.
Diet Information LabDiet® 5K52/5K67

Purchasing information

Pricing, Supply Level & Notes, Controls, General Terms & Conditions

Pricing

Pricing for USA, Canada and Mexico shipping destinations View International pricing
Weeks of AgePrice*Gender
Cryorecovery Fee $1900.00
Cryopreserved Embryos Fee $1600.00
*Price(s) in US dollars ($)

Additional Supply Details

Pricing for International shipping destinations View USA Canada and Mexico pricing
Weeks of AgePrice*Gender
Cryorecovery Fee $2470.00
Cryopreserved Embryos Fee $2080.00
*Price(s) in US dollars ($)

Additional Supply Details

Supply Details

Standard SupplyRepository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information.
Supply Notes
  • Cryopreserved Embryos
    This strain is also available as cryopreserved embryos from our Repository. Orders for cryopreserved embryos are supplied subject to a signed agreement that must be returned to the Customer Service Department after order placement. Experienced technicians at The Jackson Laboratory have recovered frozen embryos of this strain successfully. We will provide you enough embryos to perform two embryo transfers. The Jackson Laboratory does not guarantee successful recovery at your facility. For complete information on purchasing embryos from our repository, please visit our Cryopreserved Embryos web page.
  • Cryorecovery - Standard.
    The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery.

    Cryorecovery to establish a Dedicated Supply for greater quantities of mice.
    One to two pairs will be recovered to establish a Dedicated Supply of mice. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 or 1-207-288-5845.

  • This strain is included in the Type 1 Diabetes Repository collection.
  • Genomic DNA is available for this strain from the Mouse DNA Resource.

Control Information

  Control
   001976 NOD/ShiLtJ
 
  Considerations for Choosing Controls
  USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains.
  International - Control Pricing Information for Genetically Engineered Mutant Strains.

General Terms and Conditions


See Terms of Use


The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering and Purchasing Information

      Purchasing Information
      JAX® Mice Orders
      Surgical Services

Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form

Terms of Use

Terms of Use


General Terms and Conditions


For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.

Contact information

General inquiries

Contracts Administration

phone:207-288-6470
fax:207-288-6655

JAX® Mice & Services Conditions of Use

“Each recipient institution, including its employees and other researchers under its control (RECIPIENT), of mice or services using mice from The Jackson Laboratory (TJL) agrees that such mice, descendants of those mice derived by inbreeding or crossbreeding, including unmodified derivatives of those mice or their descendants (“MICE”) shall not be: (i) used for any purpose other than the internal research of the RECIPIENT, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services with respect to MICE. Acceptance of MICE from TJL shall be deemed agreement by RECIPIENT to these conditions, and departure from these conditions requires The Jackson Laboratory’s prior written authorization.”

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.

No Liability

In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.

MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.

Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.


(3.2)